INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 22,500 Value ($000) $417 Avg Close — Range —
Q2 2023
Shares 21,820 Value ($000) $241 Avg Close — Range —
Q1 2023
Shares 113,321 Value ($000) $1,522 Avg Close — Range —
Q1 2022
Shares 26,836 Value ($000) $436 Avg Close — Range —
Q4 2021
Shares 41,028 Value ($000) $669 Avg Close — Range —
Q3 2021
Shares 110,085 Value ($000) $1,635 Avg Close — Range —
Q1 2021
Shares 76,723 Value ($000) $1,772 Avg Close — Range —
Q4 2020
Shares 73,433 Value ($000) $1,814 Avg Close — Range —
Q3 2020
Shares 38,628 Value ($000) $1,602 Avg Close — Range —
Q1 2017
Shares 13,463 Value ($000) $1,521 Avg Close — Range —
Q4 2016
Shares 102,360 Value ($000) $11,121 Avg Close — Range —
Q3 2016
Shares 36,468 Value ($000) $6,002 Avg Close — Range —
Q2 2016
Shares 109,127 Value ($000) $15,570 Avg Close — Range —
Q1 2016
Shares 3,266 Value ($000) $420 Avg Close — Range —
Q3 2015
Shares 7,900 Value ($000) $1,310 Avg Close — Range —
Q2 2014
Shares 1,000 Value ($000) $237 Avg Close — Range —